Despite its importance for the development of cancer therapeutics, no global proteome study has characterized cleavage events induced by the extrinsic stimulus tumor necrosis factor–related apoptosis-inducing ligand (TRAIL), apart from one targeted study focusing on cleavage kinetics (24). Here, TNFSF10 is linked to cancer.